Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial
Titel:
Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial
Auteur:
Burns, Alistair Bernabei, Roberto Bullock, Roger Jentoft, Alfonso J Cruz Frölich, Lutz Hock, Christoph Raivio, Minna Triau, Eric Vandewoude, Maurits Wimo, Anders Came, Elizabeth Van Baelen, Bart Hammond, Gerry L van Oene, Joop C Schwalen, Susanne